title: Cross-boundary cancer studies at the University of Tokyo: Astellas in Asia: challenge for cancer.
authors: please contact Hideyuki Akaza, MD, Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan. akazah@med.rcast.u-tokyo.ac.jp.
authors: Masafumi
authors: M
authors: Nogimori
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics; D001208:Asia; D002681:China; D002986:Clinical Trials as Topic / Q000639:trends; D004345:Drug Industry; D019981:Health Care Sector; D006801:Humans; D007564:Japan; D058990:Molecular Targeted Therapy / Q000379:methods; D009369:Neoplasms / Q000188:drug therapy / Q000517:prevention & control; D011322:Primary Prevention; D014481:United States
chemical_list: D000970:Antineoplastic Agents
keywords: anticancer drug; cancer control; cross-boundary cancer studies; pharmaceutical market; the University of Tokyo